The Shotlee Journal
Browse Shotlee articles about Metabolic Health.
Showing 9 / 741 Metabolic Health articles
Country music sensation Luke Combs is turning down GLP-1 medications for weight loss, opting for the hard road instead. In a candid New York Times interview, he shares fears about his appearance affecting his career and why 'that stuff scares me more than the benefits.' This stance highlights debates around quick fixes versus lifelong habits in weight management.
A groundbreaking study in Nature Health sifted through 410,198 Reddit posts mentioning semaglutide or tirzepatide, revealing hidden side effects like reproductive issues and temperature fluctuations that go beyond typical nausea. While 43.5% of users reported symptoms, experts like Dr. Jeffrey Lee stress the need for clinical confirmation. This guide explores these findings and what they mean for patients.
Amazon is entering the GLP-1 weight loss market with a new program through One Medical and Amazon Pharmacy, promising fast, convenient access to treatments like Wegovy and Zepbound. With pricing as low as $25/month for insured patients and same-day delivery, it positions weight management as a chronic care solution. This could transform how patients access these popular medications.
A generic version of Ozempic semaglutide has received tentative USFDA approval, marking a key step toward affordable GLP-1 therapy. Orbicular spearheaded product development, partnering with OneSource Specialty Pharma as the CDMO for reliable U.S. market manufacturing. This collaboration promises steady commercial supply from an FDA-approved site.
Thirty million Americans—one in eight—are turning to GLP-1 drugs like Ozempic for weight management and more, with data showing a 20% reduced risk of heart attacks and strokes. But what happens when the weight doesn't budge, as in 10% of users? This personal story explores the hype, realities, and broader implications of these medications.
A gynaecologist at Aston University has won a £60,000 NHS research grant to probe the potential of weight-loss drugs like Ozempic and Mounjaro in treating polycystic ovary syndrome (PCOS). This initiative aims to evaluate their impact on metabolic health and fertility in affected women. Discover the project's details and why it matters for patient care.
Love Island star Shaughna Phillips is celebrating a 9kg weight loss over four months, sharing transparent before-and-after videos despite cellulite and lipoedema flare-ups. Rejecting Ozempic claims, she credits gym sessions, protein-focused eating, and her Shred It Plan. Her journey emphasizes progress over perfection for busy moms.
Marc McKee dropped nine stone with Mounjaro, transforming his health but leaving him with loose skin that inspired a new business. ElastiK Skin targets GLP-1 weight loss side effects using peptides, hyaluronic acid, and LED therapy. Early users report better hydration and elasticity with consistent use.
Stopping Ozempic often leads to weight regain—up to 7% in trials or two-thirds within a year. While continuing semaglutide helps sustain losses, lifestyle changes and maintenance dosing offer alternatives. Work with your healthcare team for a personalized plan to keep the weight off long-term.
